Dashboard
Manage Tickers

MREO


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

watching-shares-of-mereo-biopharma-group-positive-mentions-from-a-popular-newsletter
Watching Shares Of Mereo BioPharma Group; ...
08/22/2024 19:01:34

liquidia-shake-shack-and-other-big-stocks-moving-lower-in-mondays-pre-market-session
Liquidia, Shake Shack And Other Big Stocks...
08/19/2024 12:27:36

why-xperi-shares-are-trading-higher-by-around-12-here-are-20-stocks-moving-premarket
Why Xperi Shares Are Trading Higher By Aro...
08/19/2024 09:18:15

needham-reiterates-buy-on-mereo-biopharma-group-maintains-7-price-target
Needham Reiterates Buy on Mereo BioPharma ...
08/13/2024 17:58:26

Needham analyst Gil Blum reiterates Mereo BioPharma Group (NASDAQ:MREO) with a Buy and maintains $7 price target.

mereo-biopharma-group-q2-eps-002
Mereo BioPharma Group Q2 EPS $(0.02)
08/13/2024 12:26:33

Mereo BioPharma Group (NASDAQ:MREO) reported quarterly losses of $(0.02) per share.

cantor-fitzgerald-reiterates-overweight-on-mereo-biopharma-group-maintains-7-price-target
Cantor Fitzgerald Reiterates Overweight on...
07/22/2024 15:41:43

Cantor Fitzgerald analyst Kristen Kluska reiterates Mereo BioPharma Group (NASDAQ:MREO) with a Overweight and maintains $7 p...

leerink-partners-maintains-outperform-on-mereo-biopharma-group-raises-price-target-to-8
Leerink Partners Maintains Outperform on M...
06/20/2024 12:08:34

Leerink Partners analyst Joseph Schwartz maintains Mereo BioPharma Group (NASDAQ:MREO) with a Outperform and raises the pric...

mereo-biopharma-discloses-pricing-of-50m-underwritten-registered-direct-offering-of-american-depository-shares-at-a-price-of-399-per-ads-each-ads-represents-five-ordinary-shares-of-mereo
Mereo BioPharma Discloses Pricing of $50M ...
06/14/2024 11:54:43

baird-initiates-coverage-on-mereo-biopharma-group-with-outperform-rating-announces-price-target-of-8
Baird Initiates Coverage On Mereo BioPharm...
06/13/2024 09:17:24

Baird analyst Jack Allen initiates coverage on Mereo BioPharma Group (NASDAQ:MREO) with a Outperform rating and announces P...

why-streamline-health-solutions-shares-are-trading-lower-by-23-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why Streamline Health Solutions Shares Are...
06/12/2024 17:25:48

cantor-fitzgerald-reiterates-overweight-on-mereo-biopharma-group-maintains-7-price-target
Cantor Fitzgerald Reiterates Overweight on...
06/12/2024 16:16:08

Cantor Fitzgerald analyst Kristen Kluska reiterates Mereo BioPharma Group (NASDAQ:MREO) with a Overweight and maintains $7 p...

uber-to-rally-around-38-here-are-10-top-analyst-forecasts-for-wednesday
Uber To Rally Around 38%? Here Are 10 Top ...
06/12/2024 12:01:17

needham-maintains-buy-on-mereo-biopharma-group-raises-price-target-to-7
Needham Maintains Buy on Mereo BioPharma G...
06/12/2024 10:37:56

Needham analyst Gil Blum maintains Mereo BioPharma Group (NASDAQ:MREO) with a Buy and raises the price target from $6 to $7.

why-oracle-shares-are-trading-higher-by-9-here-are-20-stocks-moving-premarket
Why Oracle Shares Are Trading Higher By 9%...
06/12/2024 09:33:47

Core News & Articles
Ultragenyx, Mereo Report 14-Month Results ...
06/11/2024 21:53:19

As of a May 24, 2024 data cut-off date, treatment with setrusumab (UX143) continued to significantly reduce incidence of fractu...

cantor-fitzgerald-reiterates-overweight-on-mereo-biopharma-group-maintains-7-price-target
Cantor Fitzgerald Reiterates Overweight on...
05/16/2024 15:07:07

Cantor Fitzgerald analyst Kristen Kluska reiterates Mereo BioPharma Group (NASDAQ:MREO) with a Overweight and maintains $7 p...

needham-reiterates-buy-on-mereo-biopharma-group-maintains-6-price-target
Needham Reiterates Buy on Mereo BioPharma ...
05/16/2024 11:23:26

Needham analyst Gil Blum reiterates Mereo BioPharma Group (NASDAQ:MREO) with a Buy and maintains $6 price target.

mereo-biopharma-group-q1-2024-adj-eps-001
Mereo BioPharma Group Q1 2024 Adj EPS $(0.01)
05/15/2024 20:23:26

Mereo BioPharma Group (NASDAQ:MREO) reported quarterly losses of $(0.01) per share which missed the analyst consensus estimate ...

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/30/2024 20:31:25

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
04/29/2024 12:06:58

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION